Examining SARS-CoV-2 outbreaks in care homes for the elderly and disabled in Germany – Medical Xpress


Forget Password?
Learn more
share this!
7
4
Share
Email
November 4, 2022
by Deutsches Aerzteblatt International
The introduction of COVID-19 vaccination and additional pharmaceutical and non-pharmaceutical measures helped to notably reduce the extent and severity of SARS-CoV-19 outbreaks in care homes for elderly and disabled people in Germany. This is according to a recent study reported by Dunja Said, Beneditta Suwono, and co-authors in Deutsches Ärzteblatt International.

The authors investigated in their comparative epidemiological analysis of the time periods before and after the start of the vaccination campaign 7794 outbreaks with 177 696 outbreak cases in . 74.6% of the age group was 60 or older. The case-fatality rate among outbreak cases was 14.5%. The size and severity were compared for the following phases of the pandemic: 1, the period before had been introduced; phase 2: start of the vaccination campaigns; phase 3: the period from which a majority of the residents had been fully initially immunized. From phases 1 to 3, the median number of cases/outbreaks fell from 21 to 8. The case-fatality rate fell from 15.7% to 10.0%.
The researchers recommend that the pharmaceutical and non-pharmaceutical measures implemented in care homes should continue to be used in future, so as to prevents severe disease courses in residents. This comprises in particular a higher rate of complete vaccination, a more stringent implementation of recommendations for boosters, and the simultaneous adherence to high hygiene standards.

More information: Dunja Said et al, SARS-CoV-2 outbreaks in care homes for the elderly and disabled in Germany—a comparative epidemiological analysis of the periods before and after the beginning of the vaccination campaign, Deutsches Ärzteblatt international (2022). DOI: 10.3238/arztebl.m2022.0170
Provided by Deutsches Aerzteblatt International

Citation: Examining SARS-CoV-2 outbreaks in care homes for the elderly and disabled in Germany (2022, November 4) retrieved 7 November 2022 from https://medicalxpress.com/news/2022-11-sars-cov-outbreaks-homes-elderly-disabled.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further
Facebook
Twitter
Email
Feedback to editors
Nov 04, 2022
0
Nov 04, 2022
0
Nov 03, 2022
0
Nov 02, 2022
0
Nov 01, 2022
1
5 minutes ago
23 minutes ago
24 minutes ago
48 minutes ago
Nov 04, 2022
Nov 04, 2022
Nov 04, 2022
Jul 12, 2021
Jul 12, 2021
Sep 30, 2022
Dec 20, 2021
Feb 01, 2021
Feb 14, 2019
Nov 04, 2022
Nov 04, 2022
Nov 04, 2022
Nov 04, 2022
Nov 03, 2022
Nov 03, 2022
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.

source


0Shares

Add a Comment

Your email address will not be published.